Sensorion SA (EPA:ALSEN)
0.3870
+0.0035 (0.91%)
Apr 24, 2026, 1:53 PM CET
Sensorion Market Cap
Sensorion has a market cap or net worth of €197.4 million as of April 24, 2026. Its market cap has increased by 93.78% in one year.
Market Cap
197.40M
Enterprise Value
151.17M
Revenue
5.81M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.39
Market Cap Chart
Since April 21, 2015, Sensorion's market cap has increased from 20.46M to 197.40M, an increase of 864.96%. That is a compound annual growth rate of 22.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2026 | 197.40M | 94.95% |
| Dec 31, 2025 | 101.25M | -47.00% |
| Dec 31, 2024 | 191.03M | 137.65% |
| Dec 29, 2023 | 80.38M | 171.97% |
| Dec 30, 2022 | 29.56M | -80.74% |
| Dec 31, 2021 | 153.45M | 33.34% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Valneva SE | 450.54M |
| Genfit | 440.69M |
| Cellectis | 241.73M |
| Transgene | 206.51M |
| ABIONYX Pharma | 128.76M |
| Innate Pharma | 118.04M |
| Adocia | 112.07M |
| MaaT Pharma | 100.81M |